SMAIO signs US distribution agreement with Highridge Medical

SMAIO has announced a strategic partnership with Highridge Medical for the distribution of its KEOPS-4ME platform. Highridge Medical, a major player in the field of spinal implants in the United States, will now offer surgeons access to SMAIO's planning solutions, combined with their existing systems.

This partnership will allow SMAIO to expand its presence in the US market by leveraging Highridge Medical's network. The implants and 3D planning technology are expected to be available in early 2026, following receipt of the necessary regulatory approvals.

Philippe Roussouly, CEO of SMAIO, highlighted the importance of this agreement for the company's growth strategy in the American market, in collaboration with a recognized distributor.